Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 17, 2001

View Archived Issues

Austrian Company Intercell Raises EUR27M For Synthetic Vaccines

SkyePharma Exchanges Share Of Phase III Risk, Reward For $30M

Hybrigenics Publishes Protein Interaction Map Of H. Pylori

Avidex Completes £10M Funding For Programs In T-Cell Receptors

Peptech Anti-TNF Patents Lead To Deals With Knoll, Centocor

Cambridge Drug Eyes Licensing Deals Following £7.5M Financing

Other News To Note

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.